Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma

Oncotarget

Volumn 6, Issue 8, 2015, Pages 5666-5677

  Peng, Haoran ^a,b   Ishida, Masaharu ^a   Li, Ling ^a   Saito, Atsushi ^a   Kamiya, Atsushi ^a   Hamilton, James P ^a   Fu, Rongdang ^b   Olaru, Alexandru V ^a   An, Fangmei ^c   Popescu, Irinel ^d   Iacob, Razvan ^d   Dima, Simona ^d   Alexandrescu, Sorin T ^d   Grigorie, Razvan ^d   Nastase, Anca ^d   Berindan Neagoe, Ioana ^e,f   Tomuleasa, Ciprian ^e,f   Graur, Florin ^e,g   Zaharia, Florin ^e,g   Torbenson, Michael S ^a   Mezey, Esteban ^a   Lu, Minqiang ^b   Selaru, Florin M ^a,h   more..

^a JOHNS HOPKINS HOSPITAL   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d FUNDENI CLINICAL INSTITUTE   (Romania)

^e IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^g Regional Institute of Gastroenterology and Hepatology O Fodor   (Romania)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Competitive endogenous RNA; Hepatocellular carcinoma; INTS6; Pseudogene; Tumor suppressor

Indexed keywords

MICRORNA; MICRORNA 17 5P; UNCLASSIFIED DRUG; INTS6 PROTEIN, HUMAN; MIRN17 MICRORNA, HUMAN; RIBOSOME PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CANCER GROWTH; CANCER SIZE; CANCER TISSUE; CELL DEATH; CELL MIGRATION ASSAY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC TRANSFECTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTS6 GENE; INTS6P1 GENE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PSEUDOGENE; RNA BINDING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL PROLIFERATION; GENETICS; LIVER TUMOR; METABOLISM; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BINDING, COMPETITIVE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENES, TUMOR SUPPRESSOR; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MICE; MICRORNAS; PSEUDOGENES; RIBOSOMAL PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84925645312     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3290     Document Type: Article

References (41)

1. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature reviews. Cancer 2006;6:674-87.
2. Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nature reviews. Cancer 2013;13:123-35.
3. Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, Fei QL, Chen H, Cai B, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nature genetics 2012;44:1117-21.
4. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, Velculescu VE, Wang L, Zhou S, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nature genetics 2011;43:828-9.
5. Zhang Z. Genomic landscape of liver cancer. Nature genetics 2012;44:1075-7.
6. Thorgeirsson SS, Lee JS, Grisham JW. Functional genomics of hepatocellular carcinoma. Hepatology 2006;43:S145-50.
7. Szabo G, Bala S. MicroRNAs in liver disease. Nature reviews. Gastroenterology & hepatology 2013;10:542-52.
8. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013;152:1298-307.
9. Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z, Boldanova T, Andersen JB, Hammerle M, Tornillo L, et al. lncRNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2013.
10. Xu D, Yang F, Yuan JH, Zhang L, Bi HS, Zhou CC, Liu F, Wang F, Sun SH. Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/beta-catenin signaling. Hepatology 2013;58:739-51.
11. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F, Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic acids research 2010;38:5366-83.
12. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nature reviews. Genetics 2009;10:155-9.
13. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146:353-8.
14. Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, Krauthammer M, Halaban R, Provero P, et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011;147:382-95.
15. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, Lieberman J, Rigoutsos I, Pandolfi PP. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011;147:344-57.
16. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465:1033-8.
17. Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, Robinson DR, Wu YM, Cao X, Asangani IA, Kothari V, Prensner JR, Lonigro RJ, Iyer MK, Barrette T, Shanmugam A, et al. Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 2012;149:1622-34.
18. D'Errico I, Gadaleta G, Saccone C. Pseudogenes in metazoa: origin and features. Briefings in functional genomics & proteomics 2004;3:157-67.
19. Poliseno L. Pseudogenes: newly discovered players in human cancer. Science signaling 2012;5:re5.
20. Filleur S, Hirsch J, Wille A, Schon M, Sell C, Shearer MH, Nelius T, Wieland I. INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling. Cancer cell international 2009;9:28.
21. Hernandez M, Papadopoulos N, Almeida TA. Absence of mutations in DICE1/DDX26 gene in human cancer cell lines with frequent 13q14 deletions. Cancer genetics and cytogenetics 2005;163:91-2.
22. Li WJ, Hu N, Su H, Wang C, Goldstein AM, Wang Y, Emmert-Buck MR, Roth MJ, Guo WJ, Taylor PR. Allelic loss on chromosome 13q14 and mutation in deleted in cancer 1 gene in esophageal squamous cell carcinoma. Oncogene 2003;22:314-8.
23. Wieland I, Ropke A, Stumm M, Sell C, Weidle UH, Wieacker PF. Molecular characterization of the DICE1 (DDX26) tumor suppressor gene in lung carcinoma cells. Oncology research 2001;12:491-500.
24. Saijilafu, Hur EM, Zhou FQ. Genetic dissection of axon regeneration via in vivo electroporation of adult mouse sensory neurons. Nature communications 2011;2:543.
25. Maass PG, Luft FC, Bahring S. Long non-coding RNA in health and disease. J Mol Med (Berl) 2014.
26. Wu J, Qin Y, Li B, He WZ, Sun ZL. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Genomics 2008;91:443-50.
27. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Medical oncology 2012;29:1810-6.
28. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM, Patel T. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011;30:4750-6.
29. Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, Sugimachi K, Mimori K, Wakabayashi G, et al. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncology reports 2013;29:946-50.
30. Hirotsune S, Yoshida N, Chen A, Garrett L, Sugiyama F, Takahashi S, Yagami K, Wynshaw-Boris A, Yoshiki A. An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. Nature 2003;423:91-6.
31. Camargo AA, Nunes DN, Samaia HB, Liu L, Collins VP, Simpson AJ, Dias-Neto E. Molecular characterization of DDX26, a human DEAD-box RNA helicase, located on chromosome 7p12. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica. [et al.] 2001;34:1237-45.
32. Wieland I, Arden KC, Michels D, Klein-Hitpass L, Bohm M, Viars CS, Weidle UH. Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene 1999;18:4530-7.
33. Wieland I, Sell C, Weidle UH, Wieacker P. Ectopic expression of DICE1 suppresses tumor cell growth. Oncology reports 2004;12:207-11.
34. Ropke A, Buhtz P, Bohm M, Seger J, Wieland I, Allhoff EP, Wieacker PF. Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer. Oncogene 2005;24:6667-75.
35. El Tayebi HM, Omar K, Hegy S, El Maghrabi M, El Brolosy M, Hosny KA, Esmat G, Abdelaziz AI. Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern. Biochemical and biophysical research communications 2013;434:421-7.
36. Zheng J, Dong P, Gao S, Wang N, Yu F. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma. Hepato-gastroenterology 2013;60:549-52.
37. Yang F, Yin Y, Wang F, Wang Y, Zhang L, Tang Y, Sun S. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 2010;51:1614-23.
38. Chen L, Jiang M, Yuan W, Tang H. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. Journal of investigative surgery: the official journal of the Academy of Surgical Research 2012;25:156-61.
39. Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson M, Georgiades C, Roberts LR, Gores GJ, et al. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology 2011;54:2089-98.
40. Seraphin B, Kandels-Lewis S. An efficient PCR mutagenesis strategy without gel purification [correction of "purificiation"] step that is amenable to automation. Nucleic acids research 1996;24:3276-7.
41. Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI, Sugimachi K. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer research 2001;61:1005-12.